Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial.

By H. Bøtker, R. Kharbanda, M. Schmidt, M. Bøttcher, A. Kaltoft, C. Terkelsen, K. Munk, N. H. Andersen, T. Hansen, S. Trautner and 10 more. The Lancet, 2010

993 citations recorded by the source corpus.

Subfields: Biomedical Engineering, Pathology and Forensic Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/0cac1bffceab45b94f0fe406e7cfa61f422bee75

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Pathology and Forensic Medicine

1. D. Yellon
2. D. Hausenloy
3. H. Eltzschig
4. T. Eckle
5. G. Heusch
6. E. Murphy
7. C. Steenbergen
8. S. Cadenas

Citations in the corpus

• Ischemia and reperfusion—from mechanism to translation (2011, background): “Remote ischemic conditioning—induced by repeated brief periods of limb ischemia—was recently found to be effective in myocardial salvage in patients with acute myocardial infarctio”
• Anti-apoptosis and cell survival: a review. (2011, background): “The clinical application of remote preconditioning has shown some promise as well as some limitations [166,189,190].”
• ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. (2012, positive): “A small, randomized trial tested the value of remote conditioning using intermittent arm ischaemia through four cycles of 5 min inflations and deflation of a blood pressure cuff.(90) This was associated with improvement in surrogate markers of myocardial salvage, measured by myocardial perfusion ima”
• Myocardial ischemia-reperfusion injury: a neglected therapeutic target. (2013, positive): “(77) demonstrated that RIC applied by a paramedic to patients with STEMI in transit to the PPCI center improved myocardial salvage compared with control patients (Table 1).”
• Ischemia/Reperfusion (2016, neutral): “apies with proven efficacy in relevant patient populations (89, 109, 399, 427, 474, 565, 597, 614, 645, 809).”